Malta Government Stocks – September 2023

Issue of Malta Government Stocks

MeDirect Bank (Malta) plc is currently accepting applications for the new Malta Government Stocks (“MGS”) for a total aggregate amount of €260,000,000 subject to an over-allotment option of €140,000,000 in the event of over-subscription. Applications close on Tuesday, the 5th of September 2023 at 14:30 hrs., or earlier at the discretion of the Accountant General.

The new fixed rate bonds are:

MT0000013764 – 4.00% Malta Government Stock 2033 (IV) R

  • Interest payable semi-annually in arrears on 5th of June and the 5th of December.
  • The first interest payment will include accrued interest for the period from the 11th of September 2023 to the 4th of December 2023 (both dates inclusive) will be made on the 5th of December 2023.

The bond will be offered at €100.75 with a YTM of 3.9098% which corresponds to an annualised rate of 3.9480% and will mature on 5th of December 2033.

MT0000013798 – 4.30% Malta Government Stock 2038 (II) R

  • Interest payable semi-annually in arrears on the 15th of May and the 15th of November.
  • The first interest payment will include accrued interest for the period from the 11th of September 2023 to the 14th of November 2023 (both dates inclusive) will be made on the 15th of November 2023.

The bond will be offered at €102.00 with a YTM of 4.1210% which corresponds to an annualised rate of 4.1634% and will mature on 15th of November 2038.

The general public has the possibility of applying for these bonds in multiples of €100 and up to a maximum of €499,900 (nominal) per person.

Prospective investors are requested to read the Press Release issued by the Ministry of Finance and the Prospectus.

If you are interested in applying, please send us a Secure Mail or contact your existing Relationship Manager. For further information, please call us on (+356) 2557 4400 or send an email to

The information set forth in this article is only for informative purposes and should not be construed as an offer to sell or solicitation of an offer to subscribe for or purchase any investment. The information provided is subject to change without notice and does not constitute investment advice or any guarantee of returns. Please consider the terms and conditions governing the relevant investment prior to making any investment decision. Investors should note that at worst they may lose all of their invested principal in the event of default, insolvency and/or bankruptcy of the relevant issue. The financial instruments discussed may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

MeDirect Bank (Malta) plc has based this document on information obtained from sources it believes to be reliable but which have not been independently verified. MeDirect Bank (Malta) plc does not therefore provide any guarantees, representations or warranties. The value of any investment or income may go up as well as down and past performance is no guarantee of any future performance. When an investment is denominated in a currency other than your local or reporting currency, changes in exchange rates may have an adverse effect on your investment.

MeDirect Bank (Malta) plc, company registration number C34125, is licensed by the Malta Financial Services Authority under the Banking Act (Cap. 371) and the Investment Services Act (Cap. 370). This material shall not be reproduced in any way, whether in whole or in part. Any unauthorised disclosure, use or dissemination, either in whole or in part, of the material contained within is strictly prohibited.

MeDirect staff donate blood

A group of MeDirect employees visited the National Blood Transfusion Centre in Guardamangia to donate blood. This generous action will support the Centre to continue its essential work of ensuring sufficient supplies of blood are available to meet the needs of the major hospitals in Malta.

Blood donations serve a broad range of medical conditions. These include treating children and babies at the NPICU and treating women facing significant blood loss during childbirth. Moreover, blood plays a critical role in treating cancer patients and facilitating major surgical procedures, particularly for individuals impacted by traffic accidents or workplace mishaps.

Larissa Ciantar

Senior Manager – Mortgage Lending

“Sometimes money cannot save lives but donated blood can.”

Elaine Scicluna Lewis

Manager – Internal Audit

“Once a blood donor, always a lifesaver, so for me, being able to do something like this, is very rewarding.”

The number of annual blood donations declined significantly during Covid and have still not recovered to 2019 levels, making the need for greater awareness on the importance of donations all the more essential.

More information on donating blood can be found here.


We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to

For a comprehensive list of documentation required to open a corporate account please contact us by email at or by phone on (+356) 2557 4444.